Evidence map›Paper›PMID 37755507›Full record

ReviewApplied microbiology and biotechnology2023

Opportunities and challenges of microbial siderophores in the medical field.

Ajit Kumar Passari, Beatriz Ruiz-Villafán, Rodrigo Cruz-Bautista, Valerie Díaz-Domínguez, Romina Rodríguez-Sanoja, Sergio Sanchez

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Biodiscovery ofMicrobial genomics · 2025
    Article
  4. Review
  5. Article
  6. UropathogenicInternational journal of molecular sciences · 2025
    Article
  7. Targeting Siderophore Biosynthesis to Thwart Microbial Growth.International journal of molecular sciences · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Production and Antibacterial Activity of Atypical Siderophore fromPharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ajit Kumar Passari *Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
Beatriz Ruiz-Villafán *Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
Rodrigo Cruz-BautistaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
Valerie Díaz-DomínguezInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
Romina Rodríguez-SanojaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
Sergio SanchezInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico. sersan@biomedicas.unam.mx.ORCID http://orcid.org/0000-0002-6350-5052
Universidad Nacional Autónoma de México · MX

Funding

Consejo Nacional de Ciencia y Tecnología A1-S.9143Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN205519
6 · The paper itself

Abstract

Siderophores are low-molecular-weight secondary metabolites that function as iron chelators. Under iron-deficiency conditions, they are produced by a wide variety of microbes, allowing them to increase their iron uptake. The primary function of these compounds is the environmental iron scavenging and its transport into the cytosol. Iron is then reduced to its ferrous form to operate as an enzymatic cofactor for various functions, including respiration, nitrogen fixation, photosynthesis, methanogenesis, and amino acid synthesis. Depending on their functional group, siderophores are classified into hydroxamate, catecholate, phenolate, carboxylate, and mixed types. They have achieved great importance in recent years due to their medical applications as antimicrobial, antimalarial, or anticancer drugs, vaccines, and drug-delivery agents. This review integrates current advances in specific healthcare applications of microbial siderophores, delineating new opportunities and challenges as viable therapies to fight against diseases that represent crucial public health problems in the medical field.Key points• Siderophores are low-molecular-weight secondary metabolites functioning as iron chelators.• The siderophore's properties offer viable options to face diverse clinical problems.• Siderophores are alternatives for the enhancement of antibiotic activities.

Indexed as

SiderophoresAnti-Bacterial AgentsAnti-Infective AgentsBacteriaHumansIronIron Chelating AgentsAnti-Bacterial AgentsAnti-Infective AgentsIronIron Chelating AgentsSiderophoresAnticancerAntimalarialAntimicrobialSiderophoresVaccines

Identifiers

PMID37755507
PMCPMC10589192
OpenAlexW4387077239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.